For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Cubist Pharmaceuticals, Incorporated

USPTO Granted Patents = 59

EPO Patents = 10

Trademarks = 3

Forward Citations = 721

Loading Chart...

Loading Chart...

115 inventors (with patents filed for the assignee):

Jan-Ji Lai (12 out of 12 patents)

Chester A Metcalf, Iii (11 out of 34 patents)

Yu Gui Gu (10 out of 11 patents)

4. Dennis D Keith (10 out of 35 patents)

5. Yong He (9 out of 10 patents)

6. Ning Yin (9 out of 15 patents)

7. Dylan C Alexander (9 out of 9 patents)

8. Jason B Cross (9 out of 9 patents)

9. Paul R Schimmel (7 out of 34 patents)

10. John F Finn (7 out of 26 patents)

11. Michael Morytko (6 out of 16 patents)

12. Thomas J Kelleher (6 out of 7 patents)

13. Joseph P DeCourcey (6 out of 6 patents)

14. Paul D Lynch (6 out of 6 patents)

15. Maurizio Zenoni (6 out of 7 patents)

Core Competencies:

Lipopeptides

Beta-Lactamase Inhibitors

Antibiotic Compositions

Daptomycin

Cytokine Production Inhibitors

Gram Negative Infections

Gram Positive Infections

Heterocycles

Antibacterial Agents

Recombinant Proteins

Oral Absorption

Gene Expression

59 patents: Sort by Forward Citations

1. 9358267 - High purity lipopeptides (2016-06-07),

2. 9193729 - Inhibiting transient receptor potential ion channel TRPA1 (2015-11-24),

3. 9138456 - Lipopeptide compositions and related methods (2015-09-22),

4. 9120796 - B-lactamase inhibitor picoline salt (2015-09-01),

5. 9120795 - Crystalline form of a β-lactamase inhibitor (2015-09-01),

6. 9108966 - Beta-lactamase inhibitors (2015-08-18),

7. 9006421 - Cephalosporin compositions and methods of manufacture (2015-04-14),

8. 8969570 - Beta-lactamase inhibitors (2015-03-03),

9. 8968781 - Therapeutic compositions (2015-03-03),

10. 8962844 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors (2015-02-24),

11. 8962843 - 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors (2015-02-24),

12. 8940897 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors (2015-01-27),

13. 8933233 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors (2015-01-13),

14. 8933232 - 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors (2015-01-13),

15. 8927724 - Isoxazole beta-lactamase inhibitors (2015-01-06),

Cubist Pharmaceuticals, Incorporated is an innovative biopharmaceutical company that focuses on the discovery, development, and commercialization of novel therapies to address unmet medical needs in acute care and hospital settings. With a strong dedication to solving life-threatening infections, Cubist is committed to improving patient outcomes through its cutting-edge research and development efforts. By leveraging its expertise in antibiotic stewardship, the company has been able to bring innovative antibiotics to market, providing physicians with new tools to combat serious infections.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

59 Patents

#17 in Lexington, MA

#337 in Massachusetts

#5,907 in US

#11,951 in the World

Lexington, MA, United States of America

Cubist Pharmaceuticals, Incorporated

Forward Citations = 721

115 inventors:

Jan-Ji Lai (12 out of 12 patents)

Chester A Metcalf, Iii (11 out of 34 patents)

Yu Gui Gu (10 out of 11 patents)

4. Dennis D Keith (10 out of 35 patents)

5. Yong He (9 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…